Synapse - Genitourinary Oncology Service

Results (5696)

Efficacy and safety of endothelial growth factor receptor (VEGFR)-tyrosine kinase inhibitors (TKI) after programmed cell death 1 (PD-1) inhibitor treatment in patients with metastatic clear cell renal cell carcinoma (mccRCC)

Meeting Abstract

Nadal, R.; Amin, A.; Geynisman, D. M.; Voss, M. H.; Weinstock, M.; Doyle, J.; Zhang, Z.; Viudez, A.; Plimack, E. R.; McDermott, D. F.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Randomized phase II, three-arm trial of lenvatinib (LEN), everolimus (EVE), and LEN+EVE in patients (pts) with metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Motzer, R.; Hutson, T.; Glen, H.; Michaelson, D.; Molina, A. M.; Eisen, T.; Jassem, J.; Zolnierek, J.; Maroto, P.; Mellado, B.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

RECORD-4: A multicenter, phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Motzer, R.; Alyasova, A.; Ye, D. W.; Karpenko, A.; Li, H. Z.; Alekseev, B. Y.; Xie, L. P.; Kurteva, G. P.; Kowalyszyn, R. D.; Neron, Y.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Efficacy analysis of a phase III study of androgen deprivation therapy (ADT) +/- docetaxel (D) for men with biochemical relapse (BCR) after prostatectomy

Meeting Abstract

Morris, M. J.; Hilden, P.; Gleave, M. E.; Armstrong, A. J.; Carducci, M. A.; Saad, F.; Dayan, E. S.; Filipenko, J.; Acosta, I.; Heller, G.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Effects of radium-223 dichloride (Ra-223) with docetaxel (D) vs D on prostate-specific antigen (PSA) and bone alkaline phosphatase (bALP) in patients (pts) with castration-resistant prostate cancer (CRPC) and bone metastases (mets): A phase 1/2a clinical trial

Meeting Abstract

Morris, M. J.; Higano, C. S.; Scher, H. I.; Sweeney, C.; Antonarakis, E. S.; Shevrin, D. H.; Ryan, C. J.; Loriot, Y.; Fizazi, K.; Pandit-Taskar, N.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

A phase I study of buparlisib (BKM120) with bevacizumab (BEV) in patients (pts) with metastatic renal cell carcinoma (mRCC) progressing on prior vascular endothelial growth factor (VEGF) therapies

Meeting Abstract

McKay, R. R.; Werner, L.; Harshman, L. C.; Bellmunt, J.; Sweeney, C.; Rosenberg, J. E.; VanAllen, E.; Walsh, M. K.; Vaishampayan, U. N.; McDermott, D. F.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Analysis of real world treatment compliance in a cohort of 2,395 patients with metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Margolis, J.; Princic, N.; Doan, J.; Lenhart, G.; Motzer, R.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Early CTC decline as a biomarker of response to treatment in castration-resistant prostate cancer (CRPC): Analysis of the COU-AA-301 and IMMC38 trials

Meeting Abstract

Lorente, D.; Olmos, D.; Mateo, J.; Bianchini, D.; Seed, G.; Flohr, P.; Crespo, M.; Figueiredo, I.; Miranda, S.; Baeten, K.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Association between geographic access to cancer care and receipt of chemotherapy: Geographic distribution of oncologists and travel distance

Meeting Abstract

Lin, C. C.; Bruinooge, S. S.; Kirkwood, K. M.; Olsen, C. C.; Bajorin, D. F.; Jemal, A.; Giordano, S. H.; Goldstein, M.; Guadagnolo, B. A.; Kosty, M. P.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Novel chromosome copy number changes to predict clinical response to sunitinib in patients with advanced renal cell carcinoma

Meeting Abstract

Lee, C. H.; Motzer, R.; Hoetker, A.; Akin, O.; Molina, A. M.; Gold, T. M.; Patil, S.; Gowrishankar, B.; Houldsworth, J.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save